Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Welltower ( (WELL) ) has shared an announcement.
On July 29, 2025, Welltower Inc. filed a prospectus supplement with the SEC to register the offer and resale of up to 949,412 shares of its common stock. This filing is related to its recent acquisition of certain properties, reflecting the company’s ongoing strategic expansion in the healthcare real estate sector.
The most recent analyst rating on (WELL) stock is a Buy with a $155.00 price target. To see the full list of analyst forecasts on Welltower stock, see the WELL Stock Forecast page.
Spark’s Take on WELL Stock
According to Spark, TipRanks’ AI Analyst, WELL is a Outperform.
Welltower’s overall score reflects its robust financial performance and positive earnings call, indicating strong operational efficiency and strategic growth initiatives. However, a high P/E ratio and low dividend yield suggest potential overvaluation, which, along with macroeconomic uncertainties, are notable risks.
To see Spark’s full report on WELL stock, click here.
More about Welltower
Welltower Inc. operates in the real estate investment trust (REIT) industry, focusing on healthcare infrastructure. The company primarily invests in senior housing, post-acute communities, and outpatient medical properties, aiming to provide real estate capital to leading healthcare operators.
Average Trading Volume: 2,889,734
Technical Sentiment Signal: Buy
Current Market Cap: $103.5B
Find detailed analytics on WELL stock on TipRanks’ Stock Analysis page.